Welcome to our dedicated page for Meitav Investment House news (Ticker: MTAVF), a resource for investors and traders seeking the latest updates and insights on Meitav Investment House stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Meitav Investment House's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Meitav Investment House's position in the market.
Meitav Investment House (TASE: MTAVF) will publish its fourth quarter and full year 2025 financial statements on March 19, 2026. The investor presentation and statements will be posted on Meitav's website, MAGNA (Israel Securities Authority) and MAYA (Tel Aviv Stock Exchange).
Meitav will host an English conference call on March 19, 2026 at 1:00 p.m. ET / 7:00 p.m. Israel Time with CEO Ilan Raviv and CFO Einat Rom to review results and hold a Q&A; a webcast link is provided.